⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 21, 2024Cellular and Molecular ImmunologyOpen Access

CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors

Xin Lei Daniël C. de Groot Marij J.P. Welters Tom de Wit Ellen Schrama Hans van Eenennaam Saskia J. Santegoets Timo Oosenbrug Annemarthe G. van der Veen Joris L. Vos Charlotte L. Zuur Noel F.C.C. de Miranda Heinz Jacobs Sjoerd H. van der Burg Jannie Borst Yanling Xiao

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Cd4

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lei et al. (2024) studied this question.

synapsesocial.com/papers/68e78329b6db6435876f5e15 https://doi.org/10.1038/s41423-024-01133-1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4+ T cell helpOriginal Research · 2026
2CD4+ T cells in antitumor immunityOriginal Research · 2024 · 134 citations
3Interferon-induced lysosomal membrane permeabilization and death cause cDC1-deserts in tumorsOriginal Research · 2022 · 1 citations
4CD4 <sup>+</sup> T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy2024 · 8 citations
5Tumor-specific cytolytic CD4 T cells mediate immunity against human cancerOriginal Research · 2021 · 328 citations

Interrogating mechanisms of a novel anti-tumor CD4 response 23082162026
Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
Supplementary Data 3 from Uncoupling CD4<sup>+</sup> TIL-mediated tumor killing from JAK-signaling in melanoma2024
Designing a tumor landscape-modifying vaccine with a unique TLR2/6 agonist for refractory pancreatic cancerCellular and Molecular Immunology · 2026
Macrophage biology and immunoregulation in health and diseaseCellular and Molecular Immunology · 2026

More from Cellular and Molecular Immunology

More from Leiden University Medical Center

More from The Netherlands Cancer Institute

More from Oncode Institute